Straits Times Index
3,338.94 -9.93 (-0.30%) S&P 500
5,291.34 +7.94 (+0.15%) Dow
38,711.29 +140.26 (+0.36%) Nasdaq
16,857.05 +28.38 (+0.17%) Bitcoin USD
70,400.28 +1,245.13 (+1.80%) CMC Crypto 200
1,470.52 +23.37 (+1.62%)
Protalix BioTherapeutics, Inc. (PLX)
After hours:
| Previous close | 1.1500 |
| Open | 1.1500 |
| Bid | 1.1300 x 3100 |
| Ask | 1.2000 x 800 |
| Day's range | 1.1100 - 1.1600 |
| 52-week range | 1.0300 - 2.5100 |
| Volume | |
| Avg. volume | 429,979 |
| Market cap | 82.847M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 14.12 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Despite a dip in revenue, Protalix BioTherapeutics progresses with promising clinical trials and maintains a robust cash reserve.
- Insider Monkey
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript May 10, 2024 Protalix BioTherapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2024 Financial and Business […]
- Insider Monkey
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript March 14, 2024 Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.03. Protalix BioTherapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
